EPAS1 and colorectal carcinoma: In addition, 100% (n = 10/10) of CRC with cancer perforation showed no mutations in EPAS1 sequence, whereas 18% (n = 13/82) of CRC without mutations in EPAS1 had cancer perforation (p = 0.05).